Wed, Oct 22, 2014, 1:24 AM EDT - U.S. Markets open in 8 hrs 6 mins


% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • thirdmeinvestor thirdmeinvestor Oct 28, 2012 9:12 PM Flag

    What if Kalydeco was dosed together with VX-809 from the beginning

    Dr. White, the Phase III should last long enough to contain more than one antibiotic cycle, so that it is possible to isolate and to determine the effects of removing antibiotics. I expect that the antibiotics 'on' cycle corresponds to a higher FEV1 level and the 'off' cycle corresponds to a lower level.

    In a few months from now the Phase II data from 661 trial will be reported, and I am confident that there will be another 25+ point jump from here because the bears have to wake up from the current complacency. Good earnings and revenue from Kalydeco tomorrow, positive news for VX-787 trial, and the final relapse data from GS-7977 (unlike last year there is no Plenary or late-breaker abstracts for this molecule) are other potential wild cards.

    The future is bright for Vertex.

108.16+3.39(+3.24%)Oct 21 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.